3417 OHKI HEALTHCARE HOLDINGS CO.,LTD. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

3417

TSE Standard

OHKI HEALTHCARE HOLDINGS CO.,LTD.

867

JPY

+38

(+4.58%)

May 7, 3:30 pm JST

6.06

USD

May 7, 2:30 am EDT

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2021	270,927	2,946	4,042	2,750	199.5	20	May 17, 2021	J-GAAP
Mar, 2022	278,162	631	1,583	972	70.5	21	May 13, 2022	J-GAAP
Mar, 2023	304,445	2,059	3,153	2,182	158.2	22	May 12, 2023	J-GAAP
Mar, 2024	334,661	2,042	3,259	2,210	160.5	24	May 17, 2024	J-GAAP
Mar, 2025 Guidance	348,000	2,100	3,300	2,300	168.6	25	Nov 11, 2024	J-GAAP
YoY	+4.0%	+2.8%	+1.3%	+4.1%	+5.1%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2020	May 14, 2019	266,236	ー	ー	ー	－	J-GAAP
- - - -	May 19, 2020	266,236	ー	ー	ー	19	J-GAAP
- - - Results	May 29, 2020	277,260	2,240	3,203	2,366	19	J-GAAP
Mar, 2021	May 29, 2020	Available in future release
Results	May 17, 2021
Mar, 2022	May 17, 2021
Results	May 13, 2022
Mar, 2023	May 13, 2022
Results	May 12, 2023
Mar, 2024	May 12, 2023
Results	May 17, 2024
Mar, 2025	May 17, 2024	348,000	2,100	3,300	2,300	24	J-GAAP
	Nov 11, 2024	348,000	2,100	3,300	2,300	25	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2000	67,653	+95.9	Available in future release
Mar, 2001	66,992	-1.0
Mar, 2002	69,767	+4.1
Mar, 2003	77,058	+10.5
Mar, 2004	81,210	+5.4
Mar, 2005	85,844	+5.7
Mar, 2006	90,469	+5.4
Mar, 2007	96,768	+7.0
Mar, 2008	110,864	+14.6
Mar, 2009	129,635	+16.9
Mar, 2010	142,448	+9.9
Mar, 2011	151,141	+6.1
Mar, 2012	155,941	+3.2
Mar, 2013	168,102	+7.8
Mar, 2014	186,292	+10.8
Mar, 2015	187,765	+0.8
Mar, 2016	207,593	+10.6
Mar, 2017	222,342	+7.1
Mar, 2018	239,531	+7.7
Mar, 2019	258,481	+7.9
Mar, 2020	277,260	+7.3
Mar, 2021	270,927	-2.3
Mar, 2022	278,162	+2.7
Mar, 2023	304,445	+9.4
Mar, 2024	334,661	+9.9
Mar, 2025 Guidance	348,000	+4.0	2,100	+2.8	3,300	+1.3	168.6	+5.0

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2023	304,445	2,059	0.68	9.47	1.85	2.57	158.2
Mar, 2024	334,661	2,042	0.61	8.51	1.69	2.56	160.5
Mar, 2025 Guidance	348,000	2,100	0.60	7.48	1.49	2.25	168.6

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	334,661	2,946	4,042	2,750	199.5
Fiscal Year	Mar, 2024	Mar, 2021	Mar, 2021	Mar, 2021	Mar, 2021

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2021	136,292	43	508	241	17.5	21	May 13, 2022	J-GAAP
Oct - Mar, 2022	152,164	1,343	1,926	1,312	95.1	22	May 12, 2023	J-GAAP
Oct - Mar, 2023	167,421	861	1,477	877	63.7	24	May 17, 2024	J-GAAP
Oct - Mar, 2024 Guidance	172,972	1,279	1,847	1,312	96.2	25	Nov 11, 2024	J-GAAP
YoY	+3.3%	+48.5%	+25.1%	+49.6%	+51.1%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2022	631	1,377	1,309	68	-1,403	2,754	2.42	J-GAAP
Mar, 2023	2,059	-195	96	-291	681	3,240	2.64	J-GAAP
Mar, 2024	2,042	7,052	7,548	-496	-1,996	8,308	6.00	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	229,604	1,261	2,038	1,425	103.4	64.6	Feb 9, 2023	J-GAAP
Apr - Dec, 2023	252,669	1,406	2,312	1,592	115.5	70.9	Feb 8, 2024	J-GAAP
Apr - Dec, 2024	263,659	1,596	2,532	1,719	126.1	76.7	Feb 6, 2025	J-GAAP
YoY	+4.3%	+13.5%	+9.5%	+8.0%	+9.2%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2023	74,841	798	1,115	757	54.9	1.1	May 12, 2023	J-GAAP
Apr - Jun, 2023	81,416	246	535	529	38.4	0.3	Aug 9, 2023	J-GAAP
Jul - Sep, 2023	85,824	935	1,247	804	58.3	1.1	Nov 9, 2023	J-GAAP
Oct - Dec, 2023	85,429	225	530	259	18.8	0.3	Feb 8, 2024	J-GAAP
Jan - Mar, 2024	81,992	636	947	618	44.9	0.8	May 17, 2024	J-GAAP
Apr - Jun, 2024	87,068	287	599	402	29.5	0.3	Aug 5, 2024	J-GAAP
Jul - Sep, 2024	87,960	534	854	586	43.0	0.6	Nov 11, 2024	J-GAAP
Oct - Dec, 2024	88,631	775	1,079	731	53.6	0.9	Feb 6, 2025	J-GAAP
YoY	+3.7%	+244.4%	+103.6%	+182.2%	+185.4%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2020	68,159	+6.5	Available in future release
Apr - Jun, 2020	65,564	-4.6
Jul - Sep, 2020	72,814	+1.8
Oct - Dec, 2020	68,256	-0.9
Jan - Mar, 2021	64,293	-5.7
Apr - Jun, 2021	69,632	+6.2
Jul - Sep, 2021	72,238	-0.8
Oct - Dec, 2021	68,404	+0.2
Jan - Mar, 2022	67,888	+5.6
Apr - Jun, 2022	73,714	+5.9
Jul - Sep, 2022	78,567	+8.8
Oct - Dec, 2022	77,323	+13.0
Jan - Mar, 2023	74,841	+10.2
Apr - Jun, 2023	81,416	+10.4
Jul - Sep, 2023	85,824	+9.2
Oct - Dec, 2023	85,429	+10.5
Jan - Mar, 2024	81,992	+9.6
Apr - Jun, 2024	87,068	+6.9
Jul - Sep, 2024	87,960	+2.5
Oct - Dec, 2024	88,631	+3.7	775	+244.4	1,079	+103.6	53.6	+185.1

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	88,631	1,404	1,777	1,155	83.8
Fiscal Year	Dec, 2024	Sep, 2020	Sep, 2020	Sep, 2020	Sep, 2020

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2022	1,591.36	19.3	113,954	21,947	14,747	0.34	May 13, 2022	J-GAAP
Mar, 2023	1,749.29	19.7	122,539	24,125	16,640	0.35	May 12, 2023	J-GAAP
Mar, 2024	2,040.66	20.1	138,576	27,837	18,547	0.25	May 17, 2024	J-GAAP
Apr - Dec, 2024	ー	19.9	154,624	30,739	19,939	0.29	Feb 6, 2025	J-GAAP

OHKI HEALTHCARE HOLDINGS CO.,LTD.(3417) Financial Results